‹ All Posts
Mayank Kumar

12th Apr 2025 · SEBI-Registered Analyst

Sun Pharma

SUNPHARMA
Sun Pharma: U.S. Court of Appeals for the Federal Circuit ruled in favor of the Company related to launch of deuruxolitinib and vacated the preliminary injunction (Positive)

#FundamentalViews#TechnicalViews#Today’sTradingSetup#WatchOutFor#StockInNews
SUNPHARMA_2025-04-12_08-41-11.png
229 likes·72 comments